Immortalization of human cells by the ectopic expression of human telomerase reverse transcriptase

• US 20050123521A1
• Filed: 06/21/2002
• Published: 06/09/2005
• Est. Priority Date: 06/21/2001
• Status: Abandoned Application

• Current Assignee: Regents of the University of California (University of California)
• Original Assignee: Regents of the University of California (University of California)
• Inventors: Zern, Mark A., Wege, Henning
• Application Number:
  US10/481,191
• Publication Number:
  US 20050123521A1
• Time in Patent Office: Days
• US Class Current: 424/93.210
• CPC Class Codes: A01K 67/0271 Chimeric vertebrates, e.g. comprising exogenous cells
• CPC Class Codes: A61K 35/12 Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells vaccines or medicinal preparations containing antigens or antibodies A61K39/00
• CPC Class Codes: C12N 2510/04 Immortalised cells
• CPC Class Codes: C12N 2799/027 where the vector is derived from a retrovirus
• CPC Class Codes: C12N 5/067 Hepatocytes
• CPC Class Codes: C12N 5/0676 Pancreatic cells
• CPC Class Codes: C12N 9/1241 Nucleotidyltransferases (2.7.7)

Abstract

Immortalized primary adult and fetal human cells are provided that express a functional telomerase catalytic subunit from a nucleic acid sequence encoding the hTERT gene. The telomerase-immortalized human cells can be maintained in culture for at least 35 population doublings without developing a transformed phenotype, and while continuing to express proteins associated with the primary differentiated cell type. The invention is also directed to immortalized, non-transformed cell lines derived from primary human cells that express a functional telomerase catalytic subunit and to their use for transplantation to patients with hepatic disease. The invention also is directed to an improved biologic extracorporeal liver support device wherein the improvement is the use of telomerase-immortalized hepatocytes incorporated onto the scaffolding of the cell colonization chamber and use of the improved device for treating symptoms of patients with hepatic disease.

Claims

1. An immortalized cell, wherein said cell comprises:

a functional telomerase catalytic subunit, wherein said cell maintains at least one function specific to the cell type from which it was derived.

2. The immortalized cell according to claim 1, wherein said functional telomerase catalytic subunit is encoded by a human TERT gene.

3. The immortalized cell according to claim 1, wherein said cell is a transplantable cell.

4. The immortalized cell according to claim 3, wherein said cell is a hepatocyte or a pancreatic cell.

5. The immortalized cell according to claim 4, wherein said cell is a fetal cell.

6. The immortalized fetal cell according to claim 5, wherein % aid cell is transduced with a retrovirus.

7. The immortalized cell according to claim 4, wherein said cell is a hepatocyte and said function is (a) expression of one or more protein selected from the group consisting of albumin, α

-fetoprotein, α

1-antitrypsin, transferrin, HGF, TGFα

, TGFβ

1, TGFβ

2, HGFR, EGFR, TGFβ

1R, TGFβ

2R, FGFR, IGF-1R, HNF1α

, HNF1β

, HNF3β

, HNF4, C/EBPα

, C/EBPβ

, GAPDH;

(b) inducibility of cytochrome P450 2E1 and (c) ureagenesis.

8. The immortalized cell according to claim 4, wherein said cell is a pancreatic cell and said function is expression of at least one protein selected from the group consisting of GLUT2, insulin, glucagon, and IDX-1.

11. A bioartificial organ comprising:

a pluarility of said immortalized cell according to claim 1.

16. A bioartificial organ comprising:

a capsule and a plurality of said immortalized human cell according to claim 1.

17. A method of ameliorating at least one symptom of a metabolic disease in an individual in need thereof, said method comprising the step of:

perfusing blood of said individual through a bioartificial organ according to claim 16, whereby at least one symptom is ameliorated.

9. A non-senescent, non-transformed immortalized human cell, wherein said cell has been cultured for at least about 35 population doublings.

10. An immortalized human cell according to claim 9, wherein said cell maintains a telomere length of at least about 6 kb.

12. A method of obtaining an immortalized human cell, said method comprising the steps of:

transducing a human cell with a nucleic acid encoding a functional telomerase catalytic subunit, whereby a transduced human cell is obtained; and

growing said transduced human cell so that said nucleic acid is expressed, whereby an immortalized human cell is obtained that maintains at least one function specific to said human cell from which it was derived.

13. The method according to claim 12, wherein said human cell is a hepatocyte or a pancreatic cell.

14. The method according to claim 12 or claim 13, wherein said human cell is a fetal cell.

15. The method according to claim 12, wherein said fetal human cell is step of transducing is with a retrovirus.

18. A method of ameliorating at least one symptom of hepatic disease in an individual in need thereof, said method comprising the step of:

transplanting to said individual a plurality of immortalized human hepatocytes that express a functional telomerase catalytic subunit and maintain at least one specific hepatic function, whereby at least one symptom of said hepatic disease is ameliorated.

19. An immortalized pancreatic cell comprising:

a progenitor cell that expresses a functional telomerase catalytic subunit and maintains at least one specific pancreatic cell function.

20. The immortalized pancreatic cell according to claim 19, wherein said progenitor cell is derived from a nestin-positive islet cell.

21. The immortalized pancreatic cell according to claim 19, wherein said immortalized cell produces biologically active insulin.

22. The immortalized pancreatic cell according to claim 21, wherein said biologically active insulin is produced in response to glucose stimulation.

23. An immortalized pancreatic cell line comprising:

a plurality of said immortalized pancreatic cell according to claim 22.

24. An immortalized pancreatic cell line comprising a plurality of said immortalized pancreatic cell according to claim 21.

25. A method of treating at least one symptom of diabetes in a patient in need thereof said method comprising:

transplanting into said patient a plurality of said immortalized pancreatic cell according to claim 21.